Skip to content

menu

Proskauer Rose LLP logo
HomeAboutOur TeamContactSubscribe All Topics
Search
Close

Proskauer in Life Sciences

Developments and trends in therapeutics, pharmaceuticals, biotechnology and medical devices

federal law

Subscribe to federal law

Calls for USPTO to Adopt Policies to Modulate Drug Pricing

By Christine G. Espino on October 27, 2021

In the wake of the nomination of Kathi Vidal as Director of the USPTO, there will be significant attention paid to the agency’s responses to calls from both the executive and legislative branches to remake the agency’s perceived role in shaping the pharmaceutical pricing landscape.

Posted in Biopharmaceuticals, Generics, Patents, PTAB, Therapeutics
The Proskauer Blog Network
View All Proskauer Blogs

Proskauer in Life Sciences

Proskauer Rose LLP logo
Beijing|Boca Raton|Boston|Chicago|Hong Kong|London|Los Angeles|New Orleans|New York|Paris|São Paulo|Washington, DC
RSS LinkedIn Facebook Twitter Instagram
DisclaimerPrivacy Policy

About Proskauer Rose LLP

We are 800+ lawyers serving clients from offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. Moreover, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, private equity and venture capital firms, Fortune 500 companies, major sports leagues, entertainment industry legends and other industry-redefining companies.

Visit Proskauer.com

Topics

Archives

Copyright ©2023, Proskauer Rose LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

This website uses third party cookies, over which we have no control. To deactivate the use of third party advertising cookies, you should alter the settings in your browser.

OK